A new study in the Journal of Clinical Oncology finds women treated for early stage breast cancer who also took aspirin had a 50 percent lower risk of having the cancer spread and of dying from the disease.
Researchers speculate the aspirin reduces inflammation and thus cuts cancer risk.
Authors of the study stress that patients should not take aspirin while undergoing radiation or chemotherapy because of the risk of side effects.
Scientists say a randomized study is needed on aspirin and breast cancer death risks before it could be prescribed this way.
